VV
Vishar Vasudevan Subramanian
About Vishar Vasudevan Subramanian
Data last updated:
Vishar Vasudevan Subramanian has 24 years in corporate governance. Holds Nominee Director and Managing Director roles. Currently with 5 companies, including Malladi Drugs And Pharmaceuticals Limited and Vishar Portfolio Investment Pvt Ltd. Formerly with 6 companies, such as Strides Consumer Private Limited and Schneider Electric President Systems Limited. Engaged in General Business, Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹634 Cr; the largest is Malladi Drugs And Pharmaceuticals Limited at ₹627 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Malladi Drugs And Pharmaceuticals Limited U24230TN1980PLC008382 | Nominee Director | 28 Mar 2022 | 1980 | ₹627 Cr (FY 2025) | Active |
 Sandor Life Sciences Private Limited U85110TG2004PTC043672 | Director | 11 Jul 2020 | 2004 | ₹6.02 Cr (FY 2021) | Active |
 Hxco India Private Limited U74999HR2017PTC126979 | Director | 15 May 2017 | 2017 | ₹54.6 Lakh (FY 2025) | Active |
 Vishar Portfolio Investment Pvt Ltd U65993TG1994PTC017232 | Managing Director | 03 May 2010 | 1994 | ₹19.6 Lakh (FY 2025) | Active |
| Celix Pharmaceuticals (India) Private Limited U46497TS2024PTC187646 | Director | 18 Jul 2024 | 2024 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Strides Consumer Private Limited U24100MH2017PTC292022 | Director | 17 Feb 2020 | 2017 | ₹3.50 Cr (FY 2025) | Active |
 Schneider Electric President Systems Limited L32109KA1984PLC079103 | Director | 12 Aug 2013 | 1984 | ₹338 Cr (FY 2023) | Active |
 Schneider Electric Infrastructure Limited L31900GJ2011PLC064420 | Director | 11 Jun 2013 | 2011 | ₹2,661 Cr (FY 2025) | Active |
 Win Information Technology Private Limited U72200TG1997PTC027353 | Director | 24 Mar 2011 | 1997 | ₹24.11 Cr (FY 2024) | Active |
 Aurigene Oncology Limited U24239KA2001PLC029391 | Director | 01 May 2002 | 2001 | ₹172 Cr (FY 2025) | Active |
| Perlecan Pharma Private Limited U24239TG2005PTC047357 | Director | 05 Sep 2005 | 2005 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishar Vasudevan Subramanian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishar Vasudevan Subramanian
Vishar Vasudevan Subramanian has 24 years in corporate governance. Holds Nominee Director and Managing Director roles. Currently with 5 companies, including Malladi Drugs And Pharmaceuticals Limited and Vishar Portfolio Investment Pvt Ltd. Formerly with 6 companies, such as Strides Consumer Private Limited and Schneider Electric President Systems Limited. Engaged in General Business, Technology. The 4 current companies with reported revenue have a combined latest revenue of ₹634 Cr; the largest is Malladi Drugs And Pharmaceuticals Limited at ₹627 Cr (FY 2025).
Vishar Vasudevan Subramanian is associated with 5 companies as Nominee Director and Managing Director, including Malladi Drugs And Pharmaceuticals Limited (₹627 Cr), Sandor Life Sciences Private Limited (₹6.02 Cr), Hxco India Private Limited (₹54.6 Lakh).
Vishar Vasudevan Subramanian has expertise in General Business, Technology.
Vishar Vasudevan Subramanian has 24 years in corporate governance.
By reported revenue, the largest current company of Vishar Vasudevan Subramanian is Malladi Drugs And Pharmaceuticals Limited, with revenue of ₹627 Cr (FY 2025).
The 4 current companies of Vishar Vasudevan Subramanian that report revenue have a combined latest revenue of ₹634 Cr.
Vishar Vasudevan Subramanian currently holds positions at 5 companies: Malladi Drugs And Pharmaceuticals Limited (₹627 Cr), Sandor Life Sciences Private Limited (₹6.02 Cr), Hxco India Private Limited (₹54.6 Lakh), Vishar Portfolio Investment Pvt Ltd (₹19.6 Lakh), Celix Pharmaceuticals (India) Private Limited.